- Home
- PRTA vs NX Comparison
PRTA vs NX Comparison
Compare PRTA & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- NX
- Stock Information
- Founded
- PRTA 2012
- NX 1927
- Country
- PRTA Ireland
- NX United States
- Employees
- PRTA N/A
- NX N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- NX Metal Fabrications
- Sector
- PRTA Health Care
- NX Industrials
- Exchange
- PRTA Nasdaq
- NX Nasdaq
- Market Cap
- PRTA 809.8M
- NX 824.7M
- IPO Year
- PRTA N/A
- NX N/A
- Fundamental
- Price
- PRTA $9.70
- NX $16.40
- Analyst Decision
- PRTA Buy
- NX Strong Buy
- Analyst Count
- PRTA 9
- NX 1
- Target Price
- PRTA $54.57
- NX $38.00
- AVG Volume (30 Days)
- PRTA 605.6K
- NX 456.6K
- Earning Date
- PRTA 05-07-2025
- NX 06-05-2025
- Dividend Yield
- PRTA N/A
- NX 1.95%
- EPS Growth
- PRTA N/A
- NX N/A
- EPS
- PRTA N/A
- NX 0.29
- Revenue
- PRTA $135,157,000.00
- NX $1,438,751,000.00
- Revenue This Year
- PRTA N/A
- NX $48.92
- Revenue Next Year
- PRTA $131.71
- NX $3.10
- P/E Ratio
- PRTA N/A
- NX $56.46
- Revenue Growth
- PRTA 47.92
- NX 29.87
- 52 Week Low
- PRTA $9.00
- NX $15.30
- 52 Week High
- PRTA $25.42
- NX $35.92
- Technical
- Relative Strength Index (RSI)
- PRTA 34.03
- NX 42.16
- Support Level
- PRTA $9.00
- NX $15.30
- Resistance Level
- PRTA $10.07
- NX $16.90
- Average True Range (ATR)
- PRTA 0.74
- NX 1.07
- MACD
- PRTA 0.07
- NX 0.03
- Stochastic Oscillator
- PRTA 28.00
- NX 32.54
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.